Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies.

Baker D, Ali L, Saxena G, Pryce G, Jones M, Schmierer K, Giovannoni G, Gnanapavan S, Munger KC, Samkoff L, Goodman A, Kang AS.

Front Immunol. 2020 Feb 14;11:124. doi: 10.3389/fimmu.2020.00124. eCollection 2020.

2.

A cell-based assay for the detection of neutralizing antibodies against alemtuzumab.

Ali L, Saxena G, Jones M, Leisegang GR, Gammon L, Gnanapavan S, Giovannoni G, Schmierer K, Baker D, Kang AS.

Biotechniques. 2020 Feb 25. doi: 10.2144/btn-2019-0122. [Epub ahead of print]

3.

Induction of p53 in keratinocyte cultures treated with Behçet's patient sera.

Houacine S, Kang A, Parkinson EK, Wan H, Fortune F.

J Oral Pathol Med. 2020 Feb 15. doi: 10.1111/jop.13005. [Epub ahead of print]

PMID:
32060959
4.

GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains.

Saxena GK, Theocharopoulos I, Aziz NT, Jones M, Gnanapavan S, Giovannoni G, Schmierer K, Garnett JA, Baker D, Kang AS.

Sci Rep. 2020 Feb 5;10(1):1860. doi: 10.1038/s41598-020-58041-3.

5.

Evidence for the Desmosomal Cadherin Desmoglein-3 in Regulating YAP and Phospho-YAP in Keratinocyte Responses to Mechanical Forces.

Uttagomol J, Ahmad US, Rehman A, Huang Y, Laly AC, Kang A, Soetaert J, Chance R, Teh MT, Connelly JT, Wan H.

Int J Mol Sci. 2019 Dec 10;20(24). pii: E6221. doi: 10.3390/ijms20246221.

6.

The desmosomal cadherin desmoglein-3 acts as a keratinocyte anti-stress protein via suppression of p53.

Rehman A, Cai Y, Hünefeld C, Jedličková H, Huang Y, Teck Teh M, Sharif Ahmad U, Uttagomol J, Wang Y, Kang A, Warnes G, Harwood C, Bergamaschi D, Kenneth Parkinson E, Röcken M, Wan H.

Cell Death Dis. 2019 Oct 3;10(10):750. doi: 10.1038/s41419-019-1988-0.

7.

Alemtuzumab depletion failure can occur in multiple sclerosis.

Dubuisson N, Baker D, Kang AS, Pryce G, Marta M, Visser LH, Hofmann WE, Gnanapavan S, Giovannoni G, Schmierer K.

Immunology. 2018 Jun;154(2):253-260. doi: 10.1111/imm.12879. Epub 2018 Jan 4.

8.

Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display.

Tang J, Wang L, Markiv A, Jeffs SA, Dreja H, McKnight Á, He M, Kang AS.

Hum Antibodies. 2012;21(1-2):1-11. doi: 10.3233/HAB-2011-0257.

9.

Ribosome display of combinatorial antibody libraries derived from mice immunized with heat-killed Xylella fastidiosa and the selection of MopB-specific single-chain antibodies.

Azizi A, Arora A, Markiv A, Lampe DJ, Miller TA, Kang AS.

Appl Environ Microbiol. 2012 Apr;78(8):2638-47. doi: 10.1128/AEM.07807-11. Epub 2012 Feb 10.

10.

Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.

Markiv A, Beatson R, Burchell J, Durvasula RV, Kang AS.

BMC Biotechnol. 2011 Nov 30;11:117. doi: 10.1186/1472-6750-11-117.

11.

Paratransgenic control of vector borne diseases.

Hurwitz I, Fieck A, Read A, Hillesland H, Klein N, Kang A, Durvasula R.

Int J Biol Sci. 2011;7(9):1334-44. Epub 2011 Nov 1. Review.

12.

Development of transgenic fungi that kill human malaria parasites in mosquitoes.

Fang W, Vega-Rodríguez J, Ghosh AK, Jacobs-Lorena M, Kang A, St Leger RJ.

Science. 2011 Feb 25;331(6020):1074-7. doi: 10.1126/science.1199115.

13.

Module based antibody engineering: a novel synthetic REDantibody.

Markiv A, Anani B, Durvasula RV, Kang AS.

J Immunol Methods. 2011 Feb 1;364(1-2):40-9. doi: 10.1016/j.jim.2010.10.009. Epub 2010 Nov 3.

14.

Mosquito-bacteria symbiosis: the case of Anopheles gambiae and Asaia.

Damiani C, Ricci I, Crotti E, Rossi P, Rizzi A, Scuppa P, Capone A, Ulissi U, Epis S, Genchi M, Sagnon N, Faye I, Kang A, Chouaia B, Whitehorn C, Moussa GW, Mandrioli M, Esposito F, Sacchi L, Bandi C, Daffonchio D, Favia G.

Microb Ecol. 2010 Oct;60(3):644-54. doi: 10.1007/s00248-010-9704-8. Epub 2010 Jun 23.

PMID:
20571792
15.

Trypanosoma cruzi: synergistic cytotoxicity of multiple amphipathic anti-microbial peptides to T. cruzi and potential bacterial hosts.

Fieck A, Hurwitz I, Kang AS, Durvasula R.

Exp Parasitol. 2010 Aug;125(4):342-7. doi: 10.1016/j.exppara.2010.02.016. Epub 2010 Mar 3.

16.

Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.

Nguyen TV, Sacci JB Jr, de la Vega P, John CC, James AA, Kang AS.

Malar J. 2009 Oct 23;8:235. doi: 10.1186/1475-2875-8-235.

17.

Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.

Peterson JW, Comer JE, Noffsinger DM, Wenglikowski A, Walberg KG, Chatuev BM, Chopra AK, Stanberry LR, Kang AS, Scholz WW, Sircar J.

Infect Immun. 2006 Feb;74(2):1016-24.

18.

Cognate peptide-receptor ligand mapping by directed phage display.

Stratmann T, Kang AS.

Proteome Sci. 2005 Jun 17;3:7.

19.

Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly.

Wang F, Ruther P, Jiang I, Sawada-Hirai R, Sun SM, Nedellec R, Morrow PR, Kang AS.

Hum Antibodies. 2004;13(4):105-10.

PMID:
15671576

Supplemental Content

Loading ...
Support Center